Interestingly, Smad2/3 levels were increased in CRC tissues, and CRC patients with high Smad2/3 levels exhibited poor overall survival, indicating the clinical significance of Smad2/3 in CRC. Here, SMAD2 is linked to colorectal carcinoma.